Clinical trial

Atovaquone as Tumour HypOxia Modifier

NCT02628080

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-05-01

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2016-05-01Date precision: month

Registry last updated2019-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

AtovaquoneDRUG · verified · RxNorm: atovaquone

Sponsors & collaborators

University of Oxfordlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02628080 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.